C. Robert Horsburgh Jr, MD
Professor of Epidemiology
Boston University School of Public Health
Dept of Epidemiology

MD, Case Western Reserve University
MS, Yale University



Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Department of Biostatistics, the Department of GLobal Health and the Department of Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS and the Epidemiology of Tuberculosis. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, Peru, South Africa and Tanzania. He has served as the National Steering Committee Co-Chairman of the Tuberculosis Trials Consortium and the Tuberculosis Epidemiologic Studies Consortium. He is currently the Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials (www.resisttb.org). His office is located in the Center for Global Health and Development at BU School of Public Health.

Professor
Boston University School of Public Health
Global Health


Professor
Boston University School of Medicine
Medicine
Infectious Diseases

Professor
Boston University School of Public Health
Biostatistics


Boston Medical Center



2015 International Union Against Tuberculosis and Lung Disease, North American Region: Lifetime Achievement Award
2011 Boston University School of Public Health: Faculty Career Award in Research and Scholarship
2011 CDC: Excellence in Public Health Impact Award
2004 BUSPH: Teaching Award
1997 Emory University: Teaching Award
1989 US PHS Commendation Medal
1977 Lubrizol Award for Patient Care


PROVIDENCE/BOSTON CENTER FOR AIDS RESEARCH (CFAR): CORE SUPPORT (CORES A, B, E, G, K, SWG)
07/01/2018 - 06/30/2023 (PI)
The Miriam Hospital NIH NIAID
2P30AI042853-20A1 RE

DARTMOUTH-BOSTON UNIVERSITY HIV-TB RESEARCH TRAINING FOR THE INFECTIOUS DISEASE INSTITUTE AT MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES
06/01/2018 - 05/31/2023 (PI)
Dartmouth College NIH FIC
2D43TW009573-06

PREDICTORS OF RESISTANCE EMERGENCE EVALUATION IN MDR-TB PATIENTS ON TREATMENT (PREEMPT)
08/15/2017 - 07/31/2022 (PI)
NIH/National Institute of Allergy & Infectious Diseases
5R01AI134430-02

TUBERCULOSIS TRIALS CONSORTIUM
10/01/2014 - 09/30/2019 (PI)
Veterans Affairs Medical Center of Washington DC HHS CDC

PHASE 2 PHARMACODYNAMIC STUDY OF HIGH-DOSE LEVOFLOXACIN INMDR-TB TREATMENT
08/01/2016 - 07/31/2019 (PI)
NIH/National Institute of Allergy & Infectious Diseases
4U01AI100805-04

THE IMPACT OF ALCOHOL CONSUMPTION ON TB TREATMENT OUTCOMES
04/08/2016 - 03/31/2019 (PI)
Boston Medical Center Corporation NIH NIAID
5R01AI119037-03

BIOMARKERS FOR RISK OF TB AND FOR TB TREATMENT FAILURE AND RELAPSE
10/02/2013 - 09/30/2018 (PI)
Boston Medical Center Corporation National Science Fdn

IMPACT OF PREGNANCY ON TUBERCULOSIS
08/25/2015 - 07/31/2018 (PI)
Boston Medical Center Corporation NIH NIAID
5R01AI124217-03

BIOMARKERS AND MECHANISMS OF PAUCIBACILLARY AND LATENT TUBERCULOSIS
08/01/2014 - 07/31/2018 (PI)
Boston Medical Center Corporation NIH NIAID
5U19AI111276-04

LIFESPAN/TUFTS/BROWN CENTER FOR AIDS RESEARCH (CFAR): CORE A, CORE B, CORE G AND SWG1
07/01/2016 - 06/30/2018 (PI)
The Miriam Hospital NIH NIAID
3P30AI042853-19S1

Showing 10 of 26 results. Show All Results

BU Clinical HIV/AIDS Research Training Program
08/01/2016 - 07/31/2021 (PI)
NIH-NIAID
2T32AI052074-12

Lifespan/Tufts/brown Center for AIDS Research (CFAR): Core K Clinical Sciences Core
07/01/2016 - 06/30/2019 (PI)
Miriam Hospital NIH-NIAID

MDR-TB and HIV at RePORT Sites in India (Supplement)
08/24/2017 - 08/23/2018 (PI)
U.S. Civilian Research and Development Foundation National Science Fdn

BU Clinical HIV/AIDS Research Training Program
08/02/2010 - 07/31/2016 (PI)
NIH-NIAID
5T32AI052074-10

Boston Community Partnership Against HIV
09/30/2002 - 09/29/2005 (PI)
DHHS-Office Minority Hlth

History Of Hepatitis C Infecti
09/30/1999 - 06/30/2005 (PI)
NIH-NIDDK
5 R01 DK56410-05 & Supplement



Yr Title Project-Sub Proj Pubs
2017 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 1R01AI134430-01
2017 BU Clinical HIV/AIDS Research Training Program 5T32AI052074-12 27
2017 Clinical Core 5U19AI111276-04-7772 3
2017 Biomarkers of Persistent TB Infection and TB Treatment Relapse 5U19AI111276-04-7767 3
2016 Phase 2 Pharmacodynamic Study of High-dose Levofloxacin in MDR-TB Treatment 4U01AI100805-04
2016 BU Clinical HIV/AIDS Research Training Program 2T32AI052074-11A1 27
2016 Biomarkers of Persistent TB Infection and TB Treatment Relapse 5U19AI111276-03-7767 3
2016 Clinical Core 5U19AI111276-03-7772 3
2015 Phase 2 Pharmacodynamic Study of High-dose Levofloxacin in MDR-TB Treatment 5U01AI100805-03
2015 Biomarkers of Persistent TB Infection and TB Treatment Relapse 5U19AI111276-02-7767 3
Showing 10 of 43 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Myers B, Bouton TC, Ragan EJ, White LF, McIlleron H, Theron D, Parry CDH, Horsburgh CR, Warren RM, Jacobson KR. Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol. BMC Infect Dis. 2018 Sep 29; 18(1):488.View Related Profiles. PMID: 30268101.
     
  2. von Reyn CF, Horsburgh CR. Nontuberculous Mycobacteria and Testing for Latent Tuberculosis Infection. Clin Infect Dis. 2018 Sep 28; 67(8):1308. PMID: 29912296.
     
  3. Peloquin CA, Phillips PPJ, Mitnick CD, Eisenach K, Patientia RF, Lecca L, Gotuzzo E, Gandhi NR, Butler D, Diacon AH, Martel B, Santillan J, Hunt KR, Vargas D, von Groote-Bidlingmaier F, Seas C, Dianis N, Moreno-Martinez A, Kaur P, Horsburgh CR. Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis. Antimicrob Agents Chemother. 2018 Oct; 62(10). PMID: 30012767.
     
  4. Yuengling KA, Padayatchi N, Wolf A, Mathema B, Brown T, Horsburgh CR, O'Donnell MR. Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug Resistant Tuberculosis (XDR-TB) HIV Co-Infection Treatment in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2018 Sep 11. PMID: 30212394.
     
  5. Saag LA, Horsburgh CR. In reply. Int J Tuberc Lung Dis. 2018 Aug 01; 22(8):968. PMID: 29991411.
     
  6. Geadas C, Acuna-Villaorduna C, Mercier G, Kleinman MB, Horsburgh CR, Ellner JJ, Jacobson KR. FDG-PET/CT activity leads to the diagnosis of unsuspected TB: a retrospective study. BMC Res Notes. 2018 Jul 13; 11(1):464.View Related Profiles. PMID: 30001743.
     
  7. Horsburgh CR, Gupta A. MDR-TB in children: back to the basics. Int J Tuberc Lung Dis. 2018 May 01; 22(5):1-2. PMID: 29665946; DOI: 10.5588/ijtld.17.0834;.
     
  8. Rohr JK, Ive P, Horsburgh CR, Berhanu R, Hoffmann CJ, Wood R, Boulle A, Giddy J, Prozesky H, Vinikoor M, Mwanza MW, Wandeler G, Davies MA, Fox MP. Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes. J Acquir Immune Defic Syndr. 2018 Apr 01; 77(4):413-416.View Related Profiles. PMID: 29206723.
     
  9. Freiman JM, Jacobson KR, Muyindike WR, Horsburgh CR, Ellner JJ, Hahn JA, Linas BP. Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis. J Acquir Immune Defic Syndr. 2018 Apr 01; 77(4):405-412.View Related Profiles. PMID: 29239900.
     
  10. Saag LA, LaValley MP, Hochberg NS, Cegielski JP, Pleskunas JA, Linas BP, Horsburgh CR. Low body mass index and latent tuberculous infection: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2018 Apr 01; 22(4):358-365.View Related Profiles. PMID: 29562981; DOI: 10.5588/ijtld.17.0558;.
     
Showing 10 of 251 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 251 publications over 37 distinct years, with a maximum of 14 publications in 2011 and 2018

YearPublications
19811
19833
19844
19855
19865
19874
19884
198913
19904
19915
19928
19939
19947
19958
19965
19978
19985
19996
20008
20012
20025
20034
20045
20053
20069
20073
20087
20093
201011
201114
20128
201310
20149
201512
201611
20179
201814
Contact for Mentoring:


715 Albany St Talbot Building
Boston MA 02118
Google Map


Horsburgh's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department